$24 million for rare and neglected diseases research
NIH announces new program to develop therapeutics for rare and neglected diseases – The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases Program, or TRND.